Protagonist Therapeutics Inc (PTGX) — Cash Flow Reinvestment Rate
Protagonist Therapeutics Inc (PTGX) has a Cash Flow Reinvestment Rate of 0.76x as of March 2025, reinvesting $94.95 Million (capex $545.00K plus investments $-94.40 Million) from operating cash flow of $125.36 Million. See how much free cash does Protagonist Therapeutics Inc generate to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Protagonist Therapeutics Inc Cash Flow Reinvestment Rate (2017–2024)
Historical reinvestment intensity for Protagonist Therapeutics Inc across 2 annual periods. For the full cash flow conversion analysis, see PTGX cash generation efficiency.
Annual Cash Flow Reinvestment Rate for Protagonist Therapeutics Inc (2017–2024)
Year-by-year capital reinvestment analysis for Protagonist Therapeutics Inc. See financial flexibility index of Protagonist Therapeutics Inc to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 1.63x | $300.84 Million | $184.15 Million | $1.35 Million | ▼ -61.6% |
| 2017 | 4.26x | $16.49 Million | $3.87 Million | $666.00K | — |